United States · FDA National Drug Code directory
Cleviprex
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 18124-011_0ef540ec-3e55-44d0-b8b9-e70407a54748
- Product NDC
- 18124-011
- Form
- EMULSION
- Composition / generic term
- clevidipine
- Labeler
- Fresenius Kabi Austria GmbH
- Marketing category
- NDA
- Marketing start / end (source format)
- 20080915
- Source listing expiry
- 20261231
Source-listed ingredients
- CLEVIDIPINE — .5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 CARTON in 1 CARTON (18124-011-00) / 1 VIAL, SINGLE-USE in 1 CARTON / 100 mL in 1 VIAL, SINGLE-USE · 18124-011-00
- 4 CARTON in 1 CARTON (18124-011-25) / 1 VIAL, SINGLE-USE in 1 CARTON / 250 mL in 1 VIAL, SINGLE-USE · 18124-011-25
- 10 CARTON in 1 CARTON (18124-011-50) / 1 VIAL, SINGLE-USE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-USE · 18124-011-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →